<?xml version="1.0" encoding="utf-8"?>
<TEI xmlns="http://www.tei-c.org/ns/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:hal="http://hal.archives-ouvertes.fr/" xmlns:gml="http://www.opengis.net/gml/3.3/" xmlns:gmlce="http://www.opengis.net/gml/3.3/ce" version="1.1" xsi:schemaLocation="http://www.tei-c.org/ns/1.0 http://api.archives-ouvertes.fr/documents/aofr-sword.xsd">
  <teiHeader>
    <fileDesc>
      <titleStmt>
        <title>HAL TEI export of hal-03164872</title>
      </titleStmt>
      <publicationStmt>
        <distributor>CCSD</distributor>
        <availability status="restricted">
          <licence target="https://creativecommons.org/publicdomain/zero/1.0/">CC0 1.0 - Universal</licence>
        </availability>
        <date when="2026-05-10T19:32:39+02:00"/>
      </publicationStmt>
      <sourceDesc>
        <p part="N">HAL API Platform</p>
      </sourceDesc>
    </fileDesc>
  </teiHeader>
  <text>
    <body>
      <listBibl>
        <biblFull>
          <titleStmt>
            <title xml:lang="en">First line raltegravir/emtricitabine/tenofovir combination in HIV-2 infection: phase 2 non-comparative trial (ANRS 159 HIV-2)</title>
            <author role="aut">
              <persName>
                <forename type="first">S.</forename>
                <surname>Matheron</surname>
              </persName>
              <idno type="halauthorid">1306767-0</idno>
              <affiliation ref="#struct-1005021"/>
              <affiliation ref="#struct-300156"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">D.</forename>
                <surname>Descamps</surname>
              </persName>
              <idno type="idhal" notation="numeric">757072</idno>
              <idno type="halauthorid" notation="string">167566-757072</idno>
              <idno type="ORCID">https://orcid.org/0000-0003-0474-0551</idno>
              <idno type="IDREF">https://www.idref.fr/171332474</idno>
              <affiliation ref="#struct-1005021"/>
              <affiliation ref="#struct-300156"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">S.</forename>
                <surname>Gallien</surname>
              </persName>
              <idno type="halauthorid">403561-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Amel</forename>
                <surname>Besseghir</surname>
              </persName>
              <idno type="halauthorid">881174-0</idno>
              <affiliation ref="#struct-476572"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">P.</forename>
                <surname>Sellier</surname>
              </persName>
              <email type="md5">d098edb56e736e253a64f3db29687041</email>
              <email type="domain">gmail.com</email>
              <idno type="idhal" notation="numeric">1001520</idno>
              <idno type="halauthorid" notation="string">251756-1001520</idno>
              <idno type="ORCID">https://orcid.org/0009-0006-7229-2462</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">L.</forename>
                <surname>Blum</surname>
              </persName>
              <idno type="halauthorid">185231-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">E.</forename>
                <surname>Mortier</surname>
              </persName>
              <idno type="halauthorid">228697-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">C.</forename>
                <surname>Charpentier</surname>
              </persName>
              <idno type="halauthorid">301524-0</idno>
              <affiliation ref="#struct-1005021"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">R.</forename>
                <surname>Tubiana</surname>
              </persName>
              <idno type="halauthorid">1042187-0</idno>
              <affiliation ref="#struct-542132"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">F.</forename>
                <surname>Damond</surname>
              </persName>
              <idno type="halauthorid">2143496-0</idno>
              <affiliation ref="#struct-1005021"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">G.</forename>
                <surname>Peytavin</surname>
              </persName>
              <idno type="halauthorid">448314-0</idno>
              <affiliation ref="#struct-1005021"/>
              <affiliation ref="#struct-303171"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">D.</forename>
                <surname>Ponscarme</surname>
              </persName>
              <idno type="halauthorid">2168120-0</idno>
              <affiliation ref="#struct-506757"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">F.</forename>
                <surname>Collin</surname>
              </persName>
              <email type="md5">cc8ffd8dfbe94bae52199ac5a4a5db7d</email>
              <email type="domain">isped.u-bordeaux2.fr</email>
              <idno type="idhal" notation="numeric">842172</idno>
              <idno type="halauthorid" notation="string">437720-842172</idno>
              <affiliation ref="#struct-476572"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">F.</forename>
                <surname>Brun-Vezinet</surname>
              </persName>
              <idno type="halauthorid">1500993-0</idno>
              <affiliation ref="#struct-303171"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Geneviève</forename>
                <surname>Chene</surname>
              </persName>
              <email type="md5">0e79cbeaa65e57d0de03d25fdbb0b191</email>
              <email type="domain">isped.u-bordeaux2.fr</email>
              <idno type="idhal" notation="numeric">842202</idno>
              <idno type="halauthorid" notation="string">224169-842202</idno>
              <idno type="ORCID">https://orcid.org/0000-0002-8368-6460</idno>
              <affiliation ref="#struct-476572"/>
            </author>
            <editor role="depositor">
              <persName>
                <forename>Oskar</forename>
                <surname>Admin</surname>
              </persName>
              <email type="md5">d49c5a880544a575d14059bbcdef4ae8</email>
              <email type="domain">oskar-bordeaux.fr</email>
            </editor>
          </titleStmt>
          <editionStmt>
            <edition n="v1" type="current">
              <date type="whenSubmitted">2021-03-10 11:33:47</date>
              <date type="whenModified">2026-04-26 03:09:56</date>
              <date type="whenReleased">2021-03-10 14:18:07</date>
              <date type="whenProduced">2018</date>
              <date type="whenEndEmbargoed">2021-03-10</date>
              <ref type="file" target="https://hal.science/hal-03164872v1/document">
                <date notBefore="2021-03-10"/>
              </ref>
              <ref type="file" subtype="publisherPaid" n="1" target="https://hal.science/hal-03164872v1/file/BPH_CID_2018_Matheron.pdf" id="file-3164872-2775236">
                <date notBefore="2021-03-10"/>
              </ref>
              <ref type="externalLink" target="https://academic.oup.com/cid/article-pdf/67/8/1161/25849339/ciy245.pdf"/>
            </edition>
            <respStmt>
              <resp>contributor</resp>
              <name key="851509">
                <persName>
                  <forename>Oskar</forename>
                  <surname>Admin</surname>
                </persName>
                <email type="md5">d49c5a880544a575d14059bbcdef4ae8</email>
                <email type="domain">oskar-bordeaux.fr</email>
              </name>
            </respStmt>
          </editionStmt>
          <publicationStmt>
            <distributor>CCSD</distributor>
            <idno type="halId">hal-03164872</idno>
            <idno type="halUri">https://hal.science/hal-03164872</idno>
            <idno type="halBibtex">matheron:hal-03164872</idno>
            <idno type="halRefHtml">&lt;i&gt;Clinical Infectious Diseases&lt;/i&gt;, 2018, 67 (8), pp.1161-1167. &lt;a target="_blank" href="https://dx.doi.org/10.1093/cid/ciy245"&gt;&amp;#x27E8;10.1093/cid/ciy245&amp;#x27E9;&lt;/a&gt;</idno>
            <idno type="halRef">Clinical Infectious Diseases, 2018, 67 (8), pp.1161-1167. &amp;#x27E8;10.1093/cid/ciy245&amp;#x27E9;</idno>
            <availability status="restricted">
              <licence target="https://about.hal.science/hal-authorisation-v1/">HAL Authorization<ref corresp="#file-3164872-2775236"/></licence>
            </availability>
          </publicationStmt>
          <seriesStmt>
            <idno type="stamp" n="UNIV-PARIS13">Université Paris-Nord - Paris XIII </idno>
            <idno type="stamp" n="APHP" corresp="INSERM">AP-HP</idno>
            <idno type="stamp" n="SANTE_PUB_INSERM" corresp="INSERM">Santé Publique à l'Inserm</idno>
            <idno type="stamp" n="IPLESP" corresp="SORBONNE-UNIVERSITE">Institut Pierre Louis d'Epidémiologie et de Santé Publique</idno>
            <idno type="stamp" n="USPC">Université Sorbonne Paris Cité</idno>
            <idno type="stamp" n="IAME" corresp="UNIV-PARIS13">Infection, Anti-microbiens, Modélisation, Evolution - UMR 1137</idno>
            <idno type="stamp" n="SORBONNE-UNIVERSITE">Sorbonne Université</idno>
            <idno type="stamp" n="SORBONNE-UNIV" corresp="SORBONNE-UNIVERSITE">Sorbonne Université 01/01/2018</idno>
            <idno type="stamp" n="SU-MEDECINE" corresp="SORBONNE-UNIVERSITE">Faculté de Santé de Sorbonne Université</idno>
            <idno type="stamp" n="IBHGC" corresp="UNIV-PARIS13">Institut de Biomécanique Humaine Georges Charpak</idno>
            <idno type="stamp" n="SORBONNE-PARIS-NORD">Université Sorbonne Paris Nord</idno>
            <idno type="stamp" n="UP-SANTE">Université Paris Cité - Faculté de Santé</idno>
            <idno type="stamp" n="SU-TI">Sorbonne Université - Texte Intégral</idno>
            <idno type="stamp" n="U1219" corresp="INSERM">Bordeaux Population Health</idno>
            <idno type="stamp" n="ALLIANCE-SU"> Alliance Sorbonne Université</idno>
            <idno type="stamp" n="TEST3-HALCNRS">TEST3-HALCNRS</idno>
            <idno type="stamp" n="ACT-R" corresp="UNIV-PARIS13">Act'R </idno>
            <idno type="stamp" n="SUPRA_MEDECINE_AUTRE">Médecine (hors SVE6)</idno>
            <idno type="stamp" n="UNIVERSITE-BORDEAUX">Université de Bordeaux</idno>
          </seriesStmt>
          <notesStmt>
            <note type="audience" n="2">International</note>
            <note type="popular" n="0">No</note>
            <note type="peer" n="1">Yes</note>
          </notesStmt>
          <sourceDesc>
            <biblStruct>
              <analytic>
                <title xml:lang="en">First line raltegravir/emtricitabine/tenofovir combination in HIV-2 infection: phase 2 non-comparative trial (ANRS 159 HIV-2)</title>
                <author role="aut">
                  <persName>
                    <forename type="first">S.</forename>
                    <surname>Matheron</surname>
                  </persName>
                  <idno type="halauthorid">1306767-0</idno>
                  <affiliation ref="#struct-1005021"/>
                  <affiliation ref="#struct-300156"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">D.</forename>
                    <surname>Descamps</surname>
                  </persName>
                  <idno type="idhal" notation="numeric">757072</idno>
                  <idno type="halauthorid" notation="string">167566-757072</idno>
                  <idno type="ORCID">https://orcid.org/0000-0003-0474-0551</idno>
                  <idno type="IDREF">https://www.idref.fr/171332474</idno>
                  <affiliation ref="#struct-1005021"/>
                  <affiliation ref="#struct-300156"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">S.</forename>
                    <surname>Gallien</surname>
                  </persName>
                  <idno type="halauthorid">403561-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Amel</forename>
                    <surname>Besseghir</surname>
                  </persName>
                  <idno type="halauthorid">881174-0</idno>
                  <affiliation ref="#struct-476572"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">P.</forename>
                    <surname>Sellier</surname>
                  </persName>
                  <email type="md5">d098edb56e736e253a64f3db29687041</email>
                  <email type="domain">gmail.com</email>
                  <idno type="idhal" notation="numeric">1001520</idno>
                  <idno type="halauthorid" notation="string">251756-1001520</idno>
                  <idno type="ORCID">https://orcid.org/0009-0006-7229-2462</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">L.</forename>
                    <surname>Blum</surname>
                  </persName>
                  <idno type="halauthorid">185231-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">E.</forename>
                    <surname>Mortier</surname>
                  </persName>
                  <idno type="halauthorid">228697-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">C.</forename>
                    <surname>Charpentier</surname>
                  </persName>
                  <idno type="halauthorid">301524-0</idno>
                  <affiliation ref="#struct-1005021"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">R.</forename>
                    <surname>Tubiana</surname>
                  </persName>
                  <idno type="halauthorid">1042187-0</idno>
                  <affiliation ref="#struct-542132"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">F.</forename>
                    <surname>Damond</surname>
                  </persName>
                  <idno type="halauthorid">2143496-0</idno>
                  <affiliation ref="#struct-1005021"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">G.</forename>
                    <surname>Peytavin</surname>
                  </persName>
                  <idno type="halauthorid">448314-0</idno>
                  <affiliation ref="#struct-1005021"/>
                  <affiliation ref="#struct-303171"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">D.</forename>
                    <surname>Ponscarme</surname>
                  </persName>
                  <idno type="halauthorid">2168120-0</idno>
                  <affiliation ref="#struct-506757"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">F.</forename>
                    <surname>Collin</surname>
                  </persName>
                  <email type="md5">cc8ffd8dfbe94bae52199ac5a4a5db7d</email>
                  <email type="domain">isped.u-bordeaux2.fr</email>
                  <idno type="idhal" notation="numeric">842172</idno>
                  <idno type="halauthorid" notation="string">437720-842172</idno>
                  <affiliation ref="#struct-476572"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">F.</forename>
                    <surname>Brun-Vezinet</surname>
                  </persName>
                  <idno type="halauthorid">1500993-0</idno>
                  <affiliation ref="#struct-303171"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Geneviève</forename>
                    <surname>Chene</surname>
                  </persName>
                  <email type="md5">0e79cbeaa65e57d0de03d25fdbb0b191</email>
                  <email type="domain">isped.u-bordeaux2.fr</email>
                  <idno type="idhal" notation="numeric">842202</idno>
                  <idno type="halauthorid" notation="string">224169-842202</idno>
                  <idno type="ORCID">https://orcid.org/0000-0002-8368-6460</idno>
                  <affiliation ref="#struct-476572"/>
                </author>
              </analytic>
              <monogr>
                <idno type="halJournalId" status="VALID">11787</idno>
                <idno type="issn">1058-4838</idno>
                <idno type="eissn">1537-6591</idno>
                <title level="j">Clinical Infectious Diseases</title>
                <imprint>
                  <publisher>Oxford University Press (OUP)</publisher>
                  <biblScope unit="volume">67</biblScope>
                  <biblScope unit="issue">8</biblScope>
                  <biblScope unit="pp">1161-1167</biblScope>
                  <date type="datePub">2018</date>
                </imprint>
              </monogr>
              <idno type="doi">10.1093/cid/ciy245</idno>
            </biblStruct>
          </sourceDesc>
          <profileDesc>
            <langUsage>
              <language ident="en">English</language>
            </langUsage>
            <textClass>
              <keywords scheme="author">
                <term xml:lang="en">first line-cART</term>
                <term xml:lang="en">HIV-2</term>
                <term xml:lang="en">integrase inhibitor</term>
              </keywords>
              <classCode scheme="halDomain" n="sdv.mhep.mi">Life Sciences [q-bio]/Human health and pathology/Infectious diseases</classCode>
              <classCode scheme="halDomain" n="sdv.sp.pharma">Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology</classCode>
              <classCode scheme="halDomain" n="sdv.spee">Life Sciences [q-bio]/Santé publique et épidémiologie</classCode>
              <classCode scheme="halTypology" n="ART">Journal articles</classCode>
              <classCode scheme="halOldTypology" n="ART">Journal articles</classCode>
              <classCode scheme="halTreeTypology" n="ART">Journal articles</classCode>
            </textClass>
            <abstract xml:lang="en">
              <p>Background: New options for first-line treatment of HIV-2 infection are needed. We evaluated an integrase inhibitor (raltegravir)-containing regimen.Methods: ART-naive adults infected with HIV-2 only and history of CDC group B or C event, or a CD4 count &lt;500 cells/muL, or a CD4 decrease &gt;50 cells/muL/year over the past 3 years, or a confirmed plasma HIV-2 RNA (pVL) &gt;/=100 copies (cp)/mL were eligible for this non-comparative trial. The composite primary endpoint was survival at 48 weeks (W48) without any of the following: CD4 gain from baseline &lt;100 cells/muL, confirmed pVL &gt;/=40 cp/mL from W24, raltegravir permanent discontinuation, incident B or C event. HIV-2 ultrasensitive pVL (uspVL) and total DNA were assessed using "in-house" PCR assays.Results: Baseline median CD4 count of 30 enrolled individuals (67% women) was 436 cells/microL (InterQuartile Range[IQR] 314- 507); pVL was &gt;/=40 cp/mL in 20/30 (67%); uspVL was &gt;/=5 cp/mL in 23/25 (92%); total DNA was &gt;6 cp/PCR in 8/25 (32%). At W48, the composite endpoint of success was reached in 12/30 (40%; 95% Confidence Interval 22.7 to 59.4). Failure was mainly due to CD4 gain &lt;100 cells/microL (n=15), UspVL was &lt;5 cp/mL in 13/15 (87%) and total DNA &gt;6 cp/PCR in 3/26 (12%). Median CD4 gain was +87 cells/microL (IQR +38- +213, n=28). No serious adverse reaction was reported.Conclusion: Raltegravir-containing cART is a safe option for first line treatment of HIV-2 infection, yielding a comparable success rate to protease inhibitors. UspVL and total DNA were undetectable in the vast majority of participants.</p>
            </abstract>
          </profileDesc>
        </biblFull>
      </listBibl>
    </body>
    <back>
      <listOrg type="structures">
        <org type="laboratory" xml:id="struct-1005021" status="VALID">
          <idno type="IdRef">235514829</idno>
          <idno type="RNSR">201420743R</idno>
          <orgName>Infection, Anti-microbiens, Modélisation, Evolution</orgName>
          <orgName type="acronym">IAME (UMR_S_1137 / U1137)</orgName>
          <date type="start">2020-01-01</date>
          <desc>
            <address>
              <addrLine>Faculté de médecine Paris Diderot Paris 7 - site Bichat - 16 rue Henri Huchard 75890 Paris Cedex 18</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.iame-research.center/</ref>
          </desc>
          <listRelation>
            <relation name="U1137" active="#struct-303623" type="direct"/>
            <relation name="UMR_S_1137" active="#struct-557826" type="direct"/>
            <relation active="#struct-581146" type="direct"/>
          </listRelation>
        </org>
        <org type="institution" xml:id="struct-300156" status="VALID">
          <idno type="ROR">https://ror.org/03fdnmv92</idno>
          <orgName>AP-HP - Hôpital Bichat - Claude Bernard [Paris]</orgName>
          <desc>
            <address>
              <addrLine>46 Rue Henri Huchard, 75018 Paris</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://hupnvs.aphp.fr/bichat-claude-bernard/</ref>
          </desc>
          <listRelation>
            <relation active="#struct-300068" type="direct"/>
          </listRelation>
        </org>
        <org type="laboratory" xml:id="struct-476572" status="VALID">
          <idno type="IdRef">197398162</idno>
          <idno type="RNSR">201622170H</idno>
          <idno type="ROR">https://ror.org/00xzzba89</idno>
          <orgName>Bordeaux population health</orgName>
          <orgName type="acronym">BPH</orgName>
          <desc>
            <address>
              <addrLine>Université de Bordeaux - Case 11 - 146 rue Léo Saignat  33076 Bordeaux cedex</addrLine>
              <country key="FR"/>
            </address>
          </desc>
          <listRelation>
            <relation active="#struct-259761" type="direct"/>
            <relation active="#struct-302259" type="direct"/>
            <relation name="U1219" active="#struct-303623" type="direct"/>
          </listRelation>
        </org>
        <org type="laboratory" xml:id="struct-542132" status="VALID">
          <idno type="IdRef">186433786</idno>
          <idno type="RNSR">201420917E</idno>
          <orgName>Institut Pierre Louis d'Epidémiologie et de Santé Publique</orgName>
          <orgName type="acronym">iPLESP</orgName>
          <desc>
            <address>
              <addrLine>56, boulevard Vincent Auriol - CS 81393 - 75646 Paris Cedex 13</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.iplesp.upmc.fr/</ref>
          </desc>
          <listRelation>
            <relation name="U1136" active="#struct-303623" type="direct"/>
            <relation active="#struct-413221" type="direct"/>
          </listRelation>
        </org>
        <org type="regroupinstitution" xml:id="struct-303171" status="VALID">
          <idno type="IdRef">19077990X</idno>
          <idno type="ROR">https://ror.org/001z21q04</idno>
          <orgName>Université Sorbonne Paris Cité</orgName>
          <orgName type="acronym">USPC</orgName>
          <date type="start">2010-01-01</date>
          <desc>
            <address>
              <addrLine>Université Sorbonne Paris Cité | 100-104, avenue de France | 75013 Paris</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.sorbonne-paris-cite.fr/fr</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-506757" status="VALID">
          <idno type="IdRef">02869614X</idno>
          <idno type="ROR">https://ror.org/049am9t04</idno>
          <orgName>Hopital Saint-Louis [AP-HP]</orgName>
          <orgName type="acronym">AP-HP</orgName>
          <desc>
            <address>
              <addrLine>1 Avenue Claude Vellefaux, 75010 Paris</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://hopital-saintlouis.aphp.fr</ref>
          </desc>
          <listRelation>
            <relation active="#struct-300068" type="direct"/>
          </listRelation>
        </org>
        <org type="institution" xml:id="struct-303623" status="VALID">
          <idno type="IdRef">026388278</idno>
          <idno type="ROR">https://ror.org/02vjkv261</idno>
          <orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
          <orgName type="acronym">INSERM</orgName>
          <desc>
            <address>
              <addrLine>101, rue de Tolbiac, 75013 Paris</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.inserm.fr</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-557826" status="VALID">
          <idno type="IdRef">236453505</idno>
          <idno type="ISNI">0000 0004 7885 7602</idno>
          <idno type="ROR">https://ror.org/05f82e368</idno>
          <orgName>Université Paris Cité</orgName>
          <orgName type="acronym">UPCité</orgName>
          <date type="start">2020-01-01</date>
          <desc>
            <address>
              <addrLine>85 boulevard Saint-Germain75006 Paris</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://u-paris.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-581146" status="VALID">
          <idno type="IdRef">02640463X</idno>
          <idno type="ISNI">0000000121496883</idno>
          <idno type="ROR">https://ror.org/0199hds37</idno>
          <orgName>Université Sorbonne Paris Nord</orgName>
          <date type="start">2020-01-01</date>
          <desc>
            <address>
              <addrLine>99, avenue Jean-Baptiste Clément, 93430 Villetaneuse</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.univ-paris13.fr/</ref>
          </desc>
        </org>
        <org type="regroupinstitution" xml:id="struct-300068" status="VALID">
          <idno type="ROR">https://ror.org/00pg5jh14</idno>
          <orgName>Assistance publique - Hôpitaux de Paris (AP-HP)</orgName>
          <orgName type="acronym">AP-HP</orgName>
          <desc>
            <address>
              <country key="FR"/>
            </address>
          </desc>
        </org>
        <org type="institution" xml:id="struct-259761" status="VALID">
          <idno type="IdRef">175206562</idno>
          <idno type="ROR">https://ror.org/057qpr032</idno>
          <orgName>Université de Bordeaux</orgName>
          <orgName type="acronym">UB</orgName>
          <desc>
            <address>
              <addrLine>35, place Pey Berland - 33076 Bordeaux</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.u-bordeaux.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-302259" status="VALID">
          <orgName>Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)</orgName>
          <desc>
            <address>
              <country key="FR"/>
            </address>
          </desc>
        </org>
        <org type="regroupinstitution" xml:id="struct-413221" status="VALID">
          <idno type="IdRef">221333754</idno>
          <idno type="ROR">https://ror.org/02en5vm52</idno>
          <orgName>Sorbonne Université</orgName>
          <orgName type="acronym">SU</orgName>
          <date type="start">2018-01-01</date>
          <desc>
            <address>
              <addrLine>21 rue de l’École de médecine - 75006 Paris</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.sorbonne-universite.fr/</ref>
          </desc>
        </org>
      </listOrg>
    </back>
  </text>
</TEI>